Article Versions Notes

Shaurova T, Dy GK, Battaglia S, Hutson A, Zhang L, Zhang Y, Lovly CM, Seshadri M, Goodrich DW, Johnson CS, et al. Vitamin D3 Metabolites Demonstrate Prognostic Value in EGFR-Mutant Lung Adenocarcinoma and Can be Deployed to Oppose Acquired Therapeutic Resistance. Cancers. 2020; 12(3):675. https://doi.org/10.3390/cancers12030675

Shaurova, Tatiana, Grace K Dy, Sebastiano Battaglia, Alan Hutson, Letian Zhang, Yunkai Zhang, Christine M Lovly, Mukund Seshadri, David W Goodrich, Candace S Johnson, and et al. 2020. "Vitamin D3 Metabolites Demonstrate Prognostic Value in EGFR-Mutant Lung Adenocarcinoma and Can be Deployed to Oppose Acquired Therapeutic Resistance" Cancers 12, no. 3: 675. https://doi.org/10.3390/cancers12030675

Shaurova, T., Dy, G. K., Battaglia, S., Hutson, A., Zhang, L., Zhang, Y., Lovly, C. M., Seshadri, M., Goodrich, D. W., Johnson, C. S., & Hershberger, P. A. (2020). Vitamin D3 Metabolites Demonstrate Prognostic Value in EGFR-Mutant Lung Adenocarcinoma and Can be Deployed to Oppose Acquired Therapeutic Resistance. Cancers, 12(3), 675. https://doi.org/10.3390/cancers12030675